// App-Quantinova.ai

: Impact of Upfront Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma with Del(17) and t(4;14): A Report from the EBMT Chronic Malignancies Working Party

Researchers

Presenter

  • Nico Gagelmann

Principal Investigators

  • Simona Iacobelli

  • Helene Schoemans

  • Linda Koster

  • Denis Caillot

  • Didier Blaise

  • Pter Remnyi

  • Claude-Eric Bulabois

  • Jakob R. Passweg

  • Xavier Leleu

  • Samo Zver

  • Guido Kobbe

  • Alessandro Rambaldi

  • Patrice Chevallier

  • Mark Ringhoffer

  • Alexander M Martin

  • Urpu Salmenniemi

  • Xavier Poire

  • Stig Lenhoff

  • Pietro Pioltelli

  • Nicola Mordini

  • Hareth Nahi

  • Stefan Schnland

  • Laurent Garderet

  • Ibrahim Yakoub-Agha

  • Nicolaus Kroeger

Medical Centers

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • EBMT Statistical Unit,Leiden,Netherlands

  • University of Rome Tor Vergata, Rome, Italy

  • University Hospital Gasthuisberg, Leuven, Belgium

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Department of Urology, University Hospital, Dijon, France

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  • St. István and St. László Hospital of Budapest, Budapest, Hungary

  • Department of Hematology, CHU-Grenoble Onco-Hematologie, Grenoble, France

  • Haematology, University Hospital, Basel, Switzerland

  • Service D'Hématologie Et Thérapie Cellulaire, Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France

  • University Medical Centre, Lubjliana, Slovenia.

  • Deptartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany

  • Hematology and Bone Marrow Transplant Unit, University of Milan, ASST Papa Giovanni XXIII, Bergamo, Italy

  • Pediatric Hematology, Nantes University Hospital, Nantes, France

  • Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany

  • Leicester Royal Infirmary Haematology, Leicester, United Kingdom

  • Turku University Hospital, Turku, Finland

  • Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • Lund University Hospital, Lund, Sweden

  • Ospedale San Gerardo, Clinica Ematologica dell`Universita Milano-Biocca, Monza, Italy

  • ASO Santa Croce e Carle, SSD Reumatologia, Cuneo, Italy

  • Department of Medicine, Karolinska Institutet, Huddinge, Sweden

  • Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany

  • AP-HP, Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, Paris, France,

  • CHU de Lille, LIRIC, INSERM U995, Université de Lille, France, Lille, France

  • Department for stem cell transplantation, University Hospital, Hamburg, Germany

Locations

  • Germany

  • Netherlands

  • Italy

  • Belgium

  • France

  • Hungary

  • Switzerland

  • Slovenia

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Melphalan

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved